Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allarity Therapeutics (ALLR) Non-Current Assets (2024 - 2025)

Allarity Therapeutics' Non-Current Assets history spans 2 years, with the latest figure at $330000.0 for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 6.8% year-over-year to $330000.0; the TTM value through Dec 2025 reached $1.3 million, changed N/A, while the annual FY2025 figure was $330000.0, 6.8% up from the prior year.
  • Non-Current Assets reached $330000.0 in Q4 2025 per ALLR's latest filing, roughly flat from $330000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $9.7 million in Q1 2024 to a low of $12000.0 in Q3 2024.